Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06413498
Title A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma (iMMagine-3)
Acronym iMMagine-3
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Kite, A Gilead Company
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health RECRUITING New York New York 10016 United States Details
University of Tennessee Medical Center RECRUITING Knoxville Tennessee 37920 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field